|
1
|
Miyahara M, Tanuma J, Sugihara K and Semba
I: Tumor lymphangiogenesis correlates with lymph node metastasis
and clinicopathologic parameters in oral squamous cell carcinoma.
Cancer. 110:1287–1294. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Huang X, Wei Y, Li L, et al: Serum
proteomics study of the squamous cell carcinoma antigen 1 in tongue
cancer. Oral Oncology. 42:26–30. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bagan J, Sarrion G and Jimenez Y: Oral
cancer: clinical features. Oral Oncol. 46:414–417. 2010. View Article : Google Scholar
|
|
4
|
Pederson AW, Haraf DJ, Witt ME, et al:
Chemoradiotherapy for locoregionally advanced squamous cell
carcinoma of the base of tongue. Head Neck. 32:1519–1527. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kurita H, Yamamoto E, Nozaki S, et al:
Multicenter phase I trial of induction chemotherapy with docetaxel
and nedaplatin for oral squamous cell carcinoma. Oral Oncol.
40:1000–1006. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cranmer LD, Engelhardt C and Morgan SS:
Treatment of unresectable and metastatic cutaneous squamous cell
carcinoma. Oncologist. 15:1320–1328. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sun ML, Wang CM and Wen YM: Anticancer
effects of Pingyang mycin-activated carbon nanoparticles against
human oral squamous carcinoma Tca8113 and BcaCD885 cell lines in
vitro. Hua Xi Kou Qiang Yi Xue Za Zhi. 28:257–260. 2010.(In
Chinese).
|
|
8
|
Li WZ, Wang XY, Li ZG, et al: Celecoxib
enhances the lethal effects of bleomycin in human tongue squamous
carcinoma cell line Tca8113. Zhonghua Kou Qiang Yi Xue Za Zhi.
44:140–143. 2009.(In Chinese).
|
|
9
|
Xu Y, Luchsinger L, Lucey EC and Smith BD:
The effect of class II transactivator mutations on
bleomycin-induced lung inflammation and fibrosis. Am J Respir Cell
Mol Biol. 44:898–905. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gupta M, Fujimori A and Pommier Y:
Eukaryotic DNA topoisomerases I. Biochim Biophys Acta. 1262:1–14.
1995. View Article : Google Scholar
|
|
11
|
Saleem A, Ibrahim N, Patel M, et al:
Mechanisms of resistance in a human cell line exposed to sequential
topoisomerase poisoning. Cancer Res. 57:5100–5106. 1997.PubMed/NCBI
|
|
12
|
Zhang XW, Jiang JF and Xu B:
Differentiation-inducing action of 10-hydroxycamptothecin on human
hepatoma HepG2 cells. Acta Pharmacol Sin. 21:364–368.
2000.PubMed/NCBI
|
|
13
|
Kim NW and Wu F: Advances in
quantification and characterization of telomerase activity by the
telomeric repeat amplification protocol (TRAP). Nucleic Acid Res.
25:2595–2697. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang P, Zhang Y, Mao L, et al: Side
population in oral squamous cell carcinoma possesses tumor stem
cell phenotypes. China Journal of Oral and Maxillofacial Surgery.
8:149–153. 2010.PubMed/NCBI
|
|
15
|
Wang LJ, Yan M, Ye DX, et al: Preliminary
study on the sphere-forming stem-like cell populations of oral
squamous cell carcinoma. Zhongguo Kouqiang Hemian Waike Zazhi.
8:149–153. 2010.
|
|
16
|
Nishikawa T, Nakajima T, Katagishi T, et
al: Oxidative stress may enhance the malignant potential of human
hepatocellular carcinoma by telomerase activation. Liver Int.
29:846–856. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Iliopoulos D, Satra M, Drakaki A, et al:
Epigenetic regulation of hTERT promoter in hepatocellular
carcinomas. Int J Oncol. 34:391–399. 2009.PubMed/NCBI
|
|
18
|
Saini N, Srinivasan R, Chawla Y, et al:
Telomerase activity, telomere length and human telomerase reverse
transcriptase expression in hepatocellular carcinoma is independent
of hepatitis virus status. Liver Int. 29:1162–1170. 2009.
View Article : Google Scholar
|
|
19
|
Jiang W, Wang XW, Unger T, et al:
Cooperation of tumor-derived HBx mutants and p53-249(ser) mutant in
regulating cell proliferation, anchorage-independent growth and
aneuploidy in atelomerase-immortalized normal human
hepatocyte-derived cell line. Int J Cancer. 127:1011–1020. 2010.
View Article : Google Scholar
|
|
20
|
Zhu X, Kumar R, Mandal M, et al: Cell
cycle-dependent modulation of telomerase activity in tumor cells.
Proc Natl Acad Sci USA. 93:6091–6095. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Niculescu T, Weerth S, Soane L, et al:
Effects of membrane attack complex of complement on apoptosis in
experimental autoimmune encephalomyelitis. Ann NY Acad Sci.
1010:530–533. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Pulera MR, Adams LM, Liu H, et al:
Apoptosis in a neonatal rat model of cerebral hypoxia-ischemia.
Stroke. 29:2622–2630. 1998. View Article : Google Scholar : PubMed/NCBI
|
